308 related articles for article (PubMed ID: 31586903)
1. Epigallocatechin-3-gallate inhibits tumor angiogenesis: involvement of endoglin/Smad1 signaling in human umbilical vein endothelium cells.
Chen CY; Lin YJ; Wang CCN; Lan YH; Lan SJ; Sheu MJ
Biomed Pharmacother; 2019 Dec; 120():109491. PubMed ID: 31586903
[TBL] [Abstract][Full Text] [Related]
2. Curcuminoids Inhibit Angiogenic Behaviors of Human Umbilical Vein Endothelial Cells via Endoglin/Smad1 Signaling.
Chou YF; Lan YH; Hsiao JH; Chen CY; Chou PY; Sheu MJ
Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35409247
[TBL] [Abstract][Full Text] [Related]
3. The epigallocatechin gallate derivative Y
Liao ZH; Zhu HQ; Chen YY; Chen RL; Fu LX; Li L; Zhou H; Zhou JL; Liang G
J Ethnopharmacol; 2020 Sep; 259():112852. PubMed ID: 32278759
[TBL] [Abstract][Full Text] [Related]
4. Real Time Monitoring of Inhibition of Adipogenesis and Angiogenesis by (-)-Epigallocatechin-3-Gallate in 3T3-L1 Adipocytes and Human Umbilical Vein Endothelial Cells.
Tang W; Song H; Cai W; Shen X
Nutrients; 2015 Oct; 7(10):8871-86. PubMed ID: 26516907
[TBL] [Abstract][Full Text] [Related]
5. Bevacizumab promotes active biological behaviors of human umbilical vein endothelial cells by activating TGFβ1 pathways
Zhang X; Zhang Y; Jia Y; Qin T; Zhang C; Li Y; Huang C; Liu Z; Wang J; Li K
Cancer Biol Med; 2020 May; 17(2):418-432. PubMed ID: 32587778
[No Abstract] [Full Text] [Related]
6. (-)-Epigallocatechin-3-gallate inhibits growth of gastric cancer by reducing VEGF production and angiogenesis.
Zhu BH; Zhan WH; Li ZR; Wang Z; He YL; Peng JS; Cai SR; Ma JP; Zhang CH
World J Gastroenterol; 2007 Feb; 13(8):1162-9. PubMed ID: 17451194
[TBL] [Abstract][Full Text] [Related]
7. (-)-Epigallocatechin-3-gallate inhibits VEGF expression induced by IL-6 via Stat3 in gastric cancer.
Zhu BH; Chen HY; Zhan WH; Wang CY; Cai SR; Wang Z; Zhang CH; He YL
World J Gastroenterol; 2011 May; 17(18):2315-25. PubMed ID: 21633597
[TBL] [Abstract][Full Text] [Related]
8. Antiangiogenic mechanisms of PJ-8, a novel inhibitor of vascular endothelial growth factor receptor signaling.
Huang SW; Lien JC; Kuo SC; Huang TF
Carcinogenesis; 2012 May; 33(5):1022-30. PubMed ID: 22436611
[TBL] [Abstract][Full Text] [Related]
9. Green tea catechin, epigallocatechin-3-gallate, inhibits vascular endothelial growth factor angiogenic signaling by disrupting the formation of a receptor complex.
Rodriguez SK; Guo W; Liu L; Band MA; Paulson EK; Meydani M
Int J Cancer; 2006 Apr; 118(7):1635-44. PubMed ID: 16217757
[TBL] [Abstract][Full Text] [Related]
10. Cryptotanshinone inhibits VEGF-induced angiogenesis by targeting the VEGFR2 signaling pathway.
Xu X; Wu L; Zhou X; Zhou N; Zhuang Q; Yang J; Dai J; Wang H; Chen S; Mao W
Microvasc Res; 2017 May; 111():25-31. PubMed ID: 28040437
[TBL] [Abstract][Full Text] [Related]
11. Cultivated Orostachys japonicus extract inhibits VEGF-induced angiogenesis via regulation of VEGFR2 signaling pathway in vitro and in vivo.
Cho HD; Lee KW; Won YS; Kim JH; Seo KI
J Ethnopharmacol; 2020 Jun; 256():112664. PubMed ID: 32045685
[TBL] [Abstract][Full Text] [Related]
12. Anti-angiogenic activity and mechanism of kaurane diterpenoids from Wedelia chinensis.
Huang W; Liang Y; Wang J; Li G; Wang G; Li Y; Chung HY
Phytomedicine; 2016 Mar; 23(3):283-92. PubMed ID: 26969382
[TBL] [Abstract][Full Text] [Related]
13. Anti-angiogenic activity and intracellular distribution of epigallocatechin-3-gallate analogs.
Piyaviriyakul S; Shimizu K; Asakawa T; Kan T; Siripong P; Oku N
Biol Pharm Bull; 2011; 34(3):396-400. PubMed ID: 21372391
[TBL] [Abstract][Full Text] [Related]
14. Carvedilol may attenuate liver cirrhosis by inhibiting angiogenesis through the VEGF-Src-ERK signaling pathway.
Ding Q; Tian XG; Li Y; Wang QZ; Zhang CQ
World J Gastroenterol; 2015 Aug; 21(32):9566-76. PubMed ID: 26327764
[TBL] [Abstract][Full Text] [Related]
15. miR-342-5p Is a Notch Downstream Molecule and Regulates Multiple Angiogenic Pathways Including Notch, Vascular Endothelial Growth Factor and Transforming Growth Factor β Signaling.
Yan XC; Cao J; Liang L; Wang L; Gao F; Yang ZY; Duan JL; Chang TF; Deng SM; Liu Y; Dou GR; Zhang J; Zheng QJ; Zhang P; Han H
J Am Heart Assoc; 2016 Feb; 5(2):. PubMed ID: 26857067
[TBL] [Abstract][Full Text] [Related]
16. The natural compound codonolactone impairs tumor induced angiogenesis by downregulating BMP signaling in endothelial cells.
Wang S; Cai R; Ma J; Liu T; Ke X; Lu H; Fu J
Phytomedicine; 2015 Oct; 22(11):1017-26. PubMed ID: 26407944
[TBL] [Abstract][Full Text] [Related]
17. Anti-angiogenic effect of furanodiene on HUVECs in vitro and on zebrafish in vivo.
Zhong ZF; Hoi PM; Wu GS; Xu ZT; Tan W; Chen XP; Cui L; Wu T; Wang YT
J Ethnopharmacol; 2012 Jun; 141(2):721-7. PubMed ID: 21911050
[TBL] [Abstract][Full Text] [Related]
18. Coral-derived compound WA-25 inhibits angiogenesis by attenuating the VEGF/VEGFR2 signaling pathway.
Lin SW; Huang SC; Kuo HM; Chen CH; Ma YL; Chu TH; Bee YS; Wang EM; Wu CY; Sung PJ; Wen ZH; Wu DC; Sheu JH; Tai MH
Mar Drugs; 2015 Feb; 13(2):861-78. PubMed ID: 25668036
[TBL] [Abstract][Full Text] [Related]
19. Formononetin, a novel FGFR2 inhibitor, potently inhibits angiogenesis and tumor growth in preclinical models.
Wu XY; Xu H; Wu ZF; Chen C; Liu JY; Wu GN; Yao XQ; Liu FK; Li G; Shen L
Oncotarget; 2015 Dec; 6(42):44563-78. PubMed ID: 26575424
[TBL] [Abstract][Full Text] [Related]
20. Methylated-(3'')-epigallocatechin gallate analog suppresses tumor growth in Huh7 hepatoma cells via inhibition of angiogenesis.
Hashimoto O; Nakamura A; Nakamura T; Iwamoto H; Hiroshi M; Inoue K; Torimura T; Ueno T; Sata M
Nutr Cancer; 2014; 66(4):728-35. PubMed ID: 24033329
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
